Heart failure (HF) is a significant cause of morbidity and mortality worldwide. HF with
preserved ejection fraction (HFpEF) is a complex syndrome, often participated by several …

Cardiac troponin (cTn) is the primary biomarker for the diagnosis of myocardial necrosis in
an acute coronary syndrome (ACS). cTn levels can also be elevated in many other …

Aims The aim of this study was to evaluate whether biomarkers reflecting pathophysiological
pathways are different between heart failure with preserved (HFpEF) and reduced ejection …

Background—Elevated high-sensitivity troponin is associated with increasing disease
severity in patients with stable heart failure with reduced ejection fraction, but less is known …

Background: Levels of cTn (cardiac troponin) are frequently elevated in patients with heart
failure (HF) and reduced ejection fraction (EF) and correlate with the risk for mortality …

Background The use of cardiac biomarkers to assist in the diagnosis of occult and
symptomatic hypertrophic cardiomyopathy (HCM) in cats has been established. There is …

Importance Elevated levels of cardiac troponins are associated with adverse clinical
outcomes among patients with heart failure (HF) and reduced ejection fraction. However, the …

Rapidly assessing outcome in patients with acute decompensated heart failure is important
but prognostic factors may differ from those used routinely for stable chronic heart failure …

The signs and symptoms of heart failure are frequently unspecific and correlate poorly with
objective indices of cardiac function. Objective assessment of cardiac function by …

The TRUE‐AHF is a randomized, double‐blind, parallel‐group, placebo‐controlled trial
which is evaluating the effects of a 48‐h infusion of ularitide (15 ng/kg/min) on the short‐and …